Seminars in Nephrology
Volume 29, Issue 5 , Pages 533-538 , September 2009

Is Living Kidney Donation the Answer to the Economic Problem of End-Stage Renal Disease?

  • Scott Klarenbach, MD, MSc

      Affiliations

    • Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada
    • Institute of Health Economics, Edmonton, Alberta, Canada
    • Corresponding Author InformationAddress reprint requests to Scott Klarenbach, MD, MSc, Department of Medicine, Division of Nephrology, University of Alberta, 11-107 Clinical Sciences Building, 8440-112 St, Edmonton, Alberta, T6G 2G3 Canada
    • ,
  • Lianne Barnieh, MSc

      Affiliations

    • Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
    • ,
  • John Gill, MD, SM

      Affiliations

    • Division of Nephrology, University of British Columbia, St. Paul's Hospital, Vancouver, British Columbia, Canada

References 

  1. U.S. Renal Data Systems. USRDS 2008 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008;
  2. Nissenson AR, Rettig RA. Medicare's end-stage renal disease program: current status and future prospects. Health Aff (Millwood). 1999;18:161–179
  3. Neil N, Walker DR, Sesso R, Blackburn JC, Tschosik EA, Sciaraffia V, et al. Gaining efficiencies: resources and demand for dialysis around the globe. Value Health. 2009;12:73–79
  4. Beohar N, Erdogan AK, Lee DC, Sabbah HN, Kern MJ, Teerlink J, et al. Acute heart failure syndromes and coronary perfusion. J Am Coll Cardiol. 2008;52:13–16
  5. Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002;22:417–430
  6. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40:611–622
  7. Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50:235–242
  8. Mullins CD, Thomas SK, Pradel FG, Bartlett ST. The economic impact of laparoscopic living-donor nephrectomy on kidney transplantation. Transplantation. 2003;75:1505–1512
  9. Whiting JF, Kiberd B, Kalo Z, Keown P, Roels L, Kjerulf M. Cost-effectiveness of organ donation: evaluating investment into donor action and other donor initiatives. Am J Transplant. 2004;4:569–573
  10. Matas AJ, Schnitzler M. Payment for living donor (vendor) kidneys: a cost-effectiveness analysis. Am J Transplant. 2004;4:216–221
  11. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725–1730
  12. Mason H, Jones-Lee M, Donaldson C. Modelling the monetary value of a QALY: a new approach based on UK data. Health Econ. 2008;DOI: 10.1002/hec.1416 www.interscience.wiley.com
  13. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? (Tentative guidelines for using clinical and economic evaluations). CMAJ. 1992;146:473–481
  14. McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics. 2008;26:733–744
  15. Mendeloff J, Ko K, Roberts MS, Byrne M, Dew MA. Procuring organ donors as a health investment: how much should we be willing to spend?. Transplantation. 2004;78:1704–1710
  16. Guidelines for the economic evaluation of health technologies. Canada. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2006;
  17. van der Mei SF, Krol B, van Son WJ, de Jong PE, Groothoff J, van den Heuvel WJ. Social participation and employment status after kidney transplantation: a systematic review. Qual Life Res. 2006;15:979–994
  18. Canadian Organ Replacement Register. Preliminary report for dialysis and transplantation 2008. Ottawa: Canadian Institute for Health Information; 2008;
  19. Naghibi O, Naghibi M, Nazemian F. Factors affecting length of hospitalization in kidney transplant recipients. Exp Clin Transplant. 2007;5:614–617
  20. Smith CR, Woodward RS, Cohen DS, Singer GG, Brennan DC, Lowell JA, et al. Cadaveric versus living donor kidney transplantation: a Medicare payment analysis. Transplantation. 2000;69:311–314
  21. Boudville N, Prasad GV, Knoll G, Muirhead N, Thiessen-Philbrook H, Yang RC, et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med. 2006;145:185–196
  22. Garg AX, Muirhead N, Knoll G, Yang RC, Prasad GV, Thiessen-Philbrook H, et al. Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression. Kidney Int. 2006;70:1801–1810
  23. Gaston RS, Danovitch GM, Epstein RA, Kahn JP, Matas AJ, Schnitzler MA. Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant. 2006;6:2548–2555
  24. Schwartz J, Stegall M, Kremers W, Gloor J. Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation. Transplantation. 2006;82:155–163
  25. Segev DL, Gentry SE, Warren DS, Reeb B, Montgomery RA. Kidney paired donation and optimizing the use of live donor organs. JAMA. 2005;293:1883–1890
  26. Roth AE, Sonmez T, Unver MU. Kidney exchange. Q J Economics. 2004;May:457–488
  27. Levy AR, Sobolev B, James D, Barrable W, Clarke-Richardson P, Sullivan SD, et al. The costs of change: direct medical costs of solid organ transplantation in British Columbia, Canada, 1995-2003. Value Health. 2009;12:282–292
  28. Sheehy E, Conrad SL, Brigham LE, Luskin R, Weber P, Eakin M, et al. Estimating the number of potential organ donors in the United States. N Engl J Med. 2003;349:667–674
  29. Gill J, Klarenbach S, Cole E, Shemie S. Deceased organ donation in Canada: an opportunity to heal a fractured system. Am J Transplant. 2008;8:1580–1587
  30. Roth AE, Sonmez T, Unver MU, Delmonico FL, Saidman SL. Utilizing list exchange and nondirected donation through ‘chain’ paired kidney donations. Am J Transplant. 2006;6:2694–2705
  31. Klarenbach S, Garg AX, Vlaicu S. Living organ donors face financial barriers: a national reimbursement policy is needed. CMAJ. 2006;174:797–798
  32. Israni A, Halpern S, Zink S, Sidhwani S, Caplan A. Incentive models to increase living kidney donation: encouraging without coercing. Am J Transplant. 2005;5:15–20
  33. Rodrigue JR, Cornell DL, Lin JK, Kaplan B, Howard RJ. Increasing live donor kidney transplantation: a randomized controlled trial of a home-based educational intervention. Am J Transplant. 2007;7:394–401
  34. Miranda B, Vilardell J, Grinyo J. Optimizing cadaveric organ procurement: the Catalan and Spanish experience. Am J Transplant. 2003;3:1189–1196
  35. Boulware L, Troll M, Plantinga L, Powe N. The association of state and national legislation with living kidney donation rates in the United States: a national study. Am J Transplant. 2008;8:1451–1470
  36. Waterman A, Schenk E, Barrett A, Waterman B, Rodrigue J, Woodle E, et al. Incompatible kidney donor candidates' willingness to participate in donor-exchange and non-directed donation. Am J Transplant. 2006;6:1631–1638
  37. Waterman AD, Brennan DC. Improving patient education delivery to increase living donation rates. Am J Transplant. 2007;7:269–270
  38. Whiting JF, Woodward RS, Zavala EY, Cohen DS, Martin JE, Singer GG, et al. Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. Transplantation. 2000;70:755–760
  39. Segev DL, Gentry SE, Montgomery RA. Association between waiting times for kidney transplantation and rates of live donation. Am J Transplant. 2007;7:2406–2413

 Supported by a Population Health Investigator Award from the Alberta Heritage Foundation for Medical Research, and the Kidney Foundation of Canada (S.K.); and supported by the Michael Smith Foundation for Health Research (J.G.).

PII: S0270-9295(09)00105-3

doi: 10.1016/j.semnephrol.2009.06.010

Seminars in Nephrology
Volume 29, Issue 5 , Pages 533-538 , September 2009

Article Tools